DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (30)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 30   Next >>

Possible Reyataz side effects in 52 year old female

Reported by a physician from France on 2012-08-27

Patient: 52 year old female

Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Propranolol; Vitamin A; Truvada; Irbesartan; Ciprofloxacin Hydrochloride; Nexium; Effexor; Norvir



Possible Reyataz side effects in 52 year old female

Reported by a consumer/non-health professional from France on 2012-08-27

Patient: 52 year old female

Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Irbesartan; Effexor; Truvada; Sulfamethoxazole and Trimethoprim; Nexium; Vitamin A; Ciprofloxacin Hydrochloride; Norvir; Propranolol



Possible Reyataz side effects in 35 year old male

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 35 year old male

Reactions: Road Traffic Accident

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Carvedilol; Olanzapine; Exforge; Metformin Hydrochloride; Ritonavir; Ibuprofen; Truvada



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-13

Patient: male

Reactions: Cholelithiasis, Pancreatitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 66 year old female

Reported by a physician from Germany on 2012-08-09

Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Rhabdomyolysis, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 300 mg (300 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Simvastatin
    Dosage: 40 mg (40 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Coronary Artery Disease



Possible Reyataz side effects in 66 year old female

Reported by a individual with unspecified qualification from Germany on 2012-08-07

Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Rhabdomyolysis, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 300 mg, 1 in 1 d, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Simvastatin
    Dosage: 40 mg, 1 in 1 d, oral
    Administration route: Oral
    Indication: Coronary Artery Disease



Possible Reyataz side effects in 66 year old female

Reported by a physician from Germany on 2012-08-07

Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Rhabdomyolysis, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient possibly interacting with the suspect drug:
Simvastatin
    Dosage: for about 10 days
    Administration route: Oral
    Indication: Coronary Artery Disease



Possible Reyataz side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: male

Reactions: Adverse Event

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread

Videx

Reyataz

Norvir



Possible Reyataz side effects in male

Reported by a physician from Russian Federation on 2012-07-03

Patient: male, weighing 85.0 kg (187.0 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Dosage: 1tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-12

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-12



Possible Reyataz side effects in

Reported by a pharmacist from Germany on 2012-06-22

Patient:

Reactions: Pneumonia, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in male

Reported by a consumer/non-health professional from France on 2012-06-15

Patient: male

Reactions: Coma, Renal Failure Chronic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ritonavir

Reyataz



Possible Reyataz side effects in

Reported by a consumer/non-health professional from Germany on 2012-06-14

Patient:

Reactions: Adverse Event

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 68 year old male

Reported by a physician from Brazil on 2012-06-13

Patient: 68 year old male, weighing 64.0 kg (140.8 pounds)

Reactions: Weight Decreased, Jaundice, Scratch, Oral Disorder, Depression, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Indication: HIV Infection
    Start date: 2006-01-01

Lamivudine
    Indication: HIV Infection
    Start date: 2003-01-01

Tenofovir Disoproxil Fumarate
    Indication: HIV Infection
    Start date: 2006-01-01

Ritonavir
    Indication: HIV Infection
    Start date: 2006-01-01



Possible Reyataz side effects in

Reported by a consumer/non-health professional from Germany on 2012-05-08

Patient:

Reactions: Adverse Event

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in

Reported by a pharmacist from United States on 2012-04-06

Patient:

Reactions: Road Traffic Accident, Brain Oedema

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 53 year old male

Reported by a pharmacist from United States on 2012-03-26

Patient: 53 year old male

Reactions: Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Lortab; Calcium Carbonate; Xanax; Folic Acid; Ritonavir; Dexamethasone; Ferrous Sulfate TAB; Truvada



Possible Reyataz side effects in 71 year old male

Reported by a pharmacist from Germany on 2012-02-28

Patient: 71 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 1df:300 unit no reyataz 150
    Administration route: Oral
    Indication: HIV Infection

Norvir
    Dosage: 1df:100 unit nos
    Administration route: Oral
    Indication: HIV Infection

Abacavir Sulfate / Lamivudine
    Dosage: 1df:600/300 unit nos
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Aspirin; Ramipril; Fentanyl; Metoprolol Tartrate; Gabapentin; Norepinephrine Bitartrate; Doxazosin; Hydrochlorothiazide; Esomeprazole Sodium; Torsemide; Zopiclone; Midazolam; Linezolid; Propofol



Possible Reyataz side effects in male

Reported by a physician from United States on 2012-02-06

Patient: male

Reactions: Abdominal Pain, Hepatic Function Abnormal, Hepatitis C, Hyperthermia, Pyrexia, Oesophageal Varices Haemorrhage, Gastritis, Intestinal Mucosal Hypertrophy, Liver Function Test Abnormal, Erosive Oesophagitis, Erosive Duodenitis, Lipoatrophy, Hepatic Cirrhosis, Hepatosplenomegaly, Nausea, Anastomotic Haemorrhage, Ascites, Haemoglobin Decreased, Haematochezia, Staphylococcal Infection, Arthralgia, Arthritis Bacterial, Gastroenteritis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamivudine
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2005-04-24

Lamivudine
    Administration route: Oral
    Start date: 1997-12-29
    End date: 2005-04-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Reyataz
    Administration route: Oral
    Start date: 2004-07-30
    End date: 2005-04-24

Norvir
    Administration route: Oral
    Start date: 2008-07-14

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Truvada
    Start date: 2005-05-24

Other drugs received by patient: Emtricitabine and Tenofovir Disoproxil Fumarate; Glycine; Coagulation Factor Viii; Tenofovir Disoproxil Fumarate; Cysteine; Octocog Alfa; Glycyrrhisinic Acid; Ammonium Glycyrrhizinate; Ammonium Glycyrrhizinate



Possible Reyataz side effects in 31 year old male

Reported by a consumer/non-health professional from United States on 2012-02-01

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Other drugs received by patient: Rabeprazole Sodium; Cysteine; Glycyrrhizinic Acid; Glycine; Kogenate; Octocog Alpha; Ammonium Glycyrrhizinate



Possible Reyataz side effects in 44 year old female

Reported by a physician from Germany on 2012-01-30

Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Tubulointerstitial Nephritis, Blood Creatinine Increased, Azotaemia, Anuria, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cotrim DS
    Dosage: 480mg single dose
    Administration route: Oral
    Start date: 2011-04-13
    End date: 2011-08-19

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-04-20
    End date: 2011-08-19

Abacavir Sulfate
    Dosage: 1unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-29
    End date: 2011-08-19

Other drugs received by patient: Fluconazole; Ramipril; Citalopram; Adalat; Norvir; Truvada; Bisoprolol Fumarate and Hydrochlorothiazide



Possible Reyataz side effects in 31 year old male

Reported by a physician from United States on 2012-01-27

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Other drugs received by patient: Ammonium Glycyrrhizinate; Kogenate; Octocog Alpha; Rabeprazole Sodium; Glycine; Glycyrrhizinic Acid; Cysteine



Possible Reyataz side effects in 44 year old female

Reported by a consumer/non-health professional from Germany on 2012-01-27

Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: cumulative dose of reyataz to first adverse reaction 32700 mg
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2011-04-20
    End date: 2011-08-19

Cotrim DS
    Dosage: cumulative dose of cotrim forte to 1st adverse reaction was 58 x 0.5 tabs 1df:0.5tab
    Administration route: Oral
    Start date: 2011-04-13
    End date: 2011-08-19

Norvir
    Dosage: (dosage form 82). the cumulative dose of norvir to the first adverse reaction was 10900 mg.
    Administration route: Oral
    Start date: 2011-04-20

Truvada
    End date: 2011-07-28

Abacavir Sulfate
    Dosage: tabs 1df=82-units nos cumulative dose of kivexa to 1st adverse reaction was 9 tabs
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2011-07-29
    End date: 2011-08-19

Other drugs received by patient: Citalopram Hydrobromide; Ramipril; Bisoprolol Fumarate; Adalat; Fluconazole



Possible Reyataz side effects in 39 year old male

Reported by a consumer/non-health professional from Japan on 2012-01-27

Patient: 39 year old male

Reactions: Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 30jan04-27jul04 400 mg (180days). 28jul04-24apr05 300 mg.cap
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2005-04-24

Epivir
    Dosage: also 300mg on 25apr2005-23may2005.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Norvir
    Dosage: 28jul04-24apr05: 271 days 14jul08-cont.cap. norvir soft
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28

Viread
    Dosage: tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Other drugs received by patient: NEO-Minophagen C; Kogenate; Antihemophilic Factor (Human)



Possible Reyataz side effects in 45 year old female

Reported by a physician from France on 2011-12-13

Patient: 45 year old female

Reactions: Weight Decreased, Drug Resistance, Acute Generalised Exanthematous Pustulosis, Generalised Erythema, Castleman's Disease, Pancytopenia, Anaphylactic Shock, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2010-05-28
    End date: 2010-06-01

Sustiva
    Administration route: Oral

Prezista
    Start date: 2010-05-28
    End date: 2010-06-01

Nevirapine

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Isentress
    Administration route: Oral
    Start date: 2010-08-17
    End date: 2010-01-01

Viread
    Start date: 2010-05-28
    End date: 2010-06-01

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Viread
    Start date: 2010-08-11
    End date: 2010-08-11

Other drugs received by patient: Piascledine



Possible Reyataz side effects in 50 year old male

Reported by a physician from Spain on 2011-11-24

Patient: 50 year old male

Reactions: Hepatic Neoplasm Malignant, Hepatitis C, Cholestasis, Hepatic Cirrhosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: total dose 400mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-01-01
    End date: 2010-12-06

Esomeprazole
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-10-29
    End date: 2010-12-02

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2010-12-06

Other drugs received by patient: Sumial; Diazepam



Possible Reyataz side effects in 45 year old female

Reported by a physician from France on 2011-11-23

Patient: 45 year old female

Reactions: Weight Decreased, Drug Resistance, Generalised Erythema, Acute Generalised Exanthematous Pustulosis, Castleman's Disease, Anaphylactic Shock, Pancytopenia, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2010-05-28
    End date: 2010-06-01

Viread
    Start date: 2010-08-11
    End date: 2010-08-11

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Prezista
    Start date: 2010-05-28
    End date: 2010-06-01

Isentress
    Administration route: Oral
    Start date: 2010-08-17
    End date: 2010-01-01

Sustiva
    Administration route: Oral

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Viread
    Start date: 2010-05-28
    End date: 2010-06-01

Nevirapine

Other drugs received by patient: Piascledine



Possible Reyataz side effects in 45 year old female

Reported by a consumer/non-health professional from France on 2011-11-20

Patient: 45 year old female

Reactions: Weight Decreased, Acute Generalised Exanthematous Pustulosis, Drug Resistance, Castleman's Disease, Pancytopenia, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: reintroduced on 19aug10
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Prezista

Isentress
    Dosage: reintroduced 17aug10,isentress 400mg film-coated tablet.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Efavirenz

Viread
    Start date: 2010-08-11

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Norvir
    Indication: HIV Infection
    Start date: 2010-05-28

Other drugs received by patient: Piascledine



Possible Reyataz side effects in 50 year old male

Reported by a physician from Spain on 2011-11-15

Patient: 50 year old male

Reactions: Cholestasis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Esomeprazol / 01479301 /
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-10-29
    End date: 2010-12-02

Nexavar
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2010-10-29
    End date: 2010-12-02

Reyataz
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-01-01
    End date: 2010-12-06

Truvada
    Dosage: 245 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2010-12-06

Other drugs received by patient: Diazepam; Sumial



Possible Reyataz side effects in 50 year old male

Reported by a physician from Spain on 2011-11-14

Patient: 50 year old male

Reactions: Blood Bilirubin Increased, Musculoskeletal Pain, Cholestasis, Terminal State

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Nexavar
    Dosage: 400 mg, hs
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2010-10-29
    End date: 2010-12-02

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-01-01
    End date: 2010-12-06

Esomeprazole
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-10-29
    End date: 2010-12-02

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2010-12-06

Other drugs received by patient: Sumial; Diazepam



Possible Reyataz side effects in

Reported by a pharmacist from United States on 2011-11-02

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Baraclude
    Indication: Hepatitis B

Reyataz
    Indication: HIV Infection

Other drugs received by patient: Efavirenz; Isentress



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012